Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XIPERE ®safely and effectively. See full prescribing information for XIPERE ®. XIPERE ®(triamcinolone acetonide injectable suspension), for suprachoroidal use Initial U.S. Approval: 1957
Medication labelWhy this: Advisory · dailymed-prescription
XIPERE ®(triamcinolone acetonide injectable suspension) 40 mg/mL is indicated for the treatment of macular edema associated with uveitis.
- generic_name
- triamcinolone acetonide
- product_names
- triamcinolone acetonide
- ndc
- 24208-040, 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en